CureVac N.V (CVAC) EBIAT: 2019-2025
Historic EBIAT for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -$68.3 million.
- CureVac N.V's EBIAT rose 9.27% to -$68.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $214.0 million, marking a year-over-year increase of 172.12%. This contributed to the annual value of $173.3 million for FY2024, which is 161.91% up from last year.
- According to the latest figures from Q2 2025, CureVac N.V's EBIAT is -$68.3 million, which was down 26.83% from -$53.9 million recorded in Q1 2025.
- In the past 5 years, CureVac N.V's EBIAT ranged from a high of $318.6 billion in Q2 2021 and a low of -$133.6 million during Q1 2021.
- Over the past 3 years, CureVac N.V's median EBIAT value was -$65.0 million (recorded in 2023), while the average stood at -$21.8 million.
- Its EBIAT has fluctuated over the past 5 years, first surged by 135,019,749.14% in 2021, then crashed by 5,817.88% in 2022.
- CureVac N.V's EBIAT (Quarterly) stood at -$2.2 million in 2021, then crashed by 5,817.88% to -$131.1 million in 2022, then climbed by 28.86% to -$93.2 million in 2023, then soared by 62.45% to -$35.0 million in 2024, then rose by 9.27% to -$68.3 million in 2025.
- Its last three reported values are -$68.3 million in Q2 2025, -$53.9 million for Q1 2025, and -$35.0 million during Q4 2024.